Danaher (DHR) Cash from Financing Activities (2009 - 2026)
Danaher (DHR) posted quarterly Cash from Financing Activities of $7.3 billion for Q2 2026, up 3044.53% year-over-year from $231.3 million in Q2 2025, and up 15710.87% quarter-over-quarter from $46.0 million in Q1 2026.
Danaher (DHR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Danaher's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at $7.3 billion for Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 3044.53% year-over-year to $7.3 billion; the TTM figure through Jun 2026 stood at $5.9 billion (up 245.09% YoY), while the FY2025 annual figure was -$3.0 billion, up 64.69% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at $7.3 billion, up from $46.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $7.3 billion in Q2 2026, with the low at -$5.7 billion in Q2 2024.
- The 5-year median for Cash from Financing Activities is -$268.0 million (2022), against an average of -$381.7 million.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities slumped 2647.6% in 2024, then soared 3044.53% in 2026.
- Danaher's Cash from Financing Activities stood at -$906.0 million in 2022, then slumped by 147.9% to -$2.2 billion in 2023, then increased by 24.67% to -$1.7 billion in 2024, then surged by 178.13% to $1.3 billion in 2025, then jumped by 450.15% to $7.3 billion in 2026.
- Business Quant data shows DHR's Cash from Financing Activities at $7.3 billion in Q2 2026, $46.0 million in Q1 2026, and $1.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 580.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 7.27 Bn |
| Jun 26, 2026 | 7.27 Bn |
| Mar 27, 2026 | 46.00 Mn |
| Mar 27, 2026 | 46.00 Mn |
| Dec 31, 2025 | 1.32 Bn |
| Dec 31, 2025 | 1.32 Bn |
| Sep 26, 2025 | -2.78 Bn |
| Sep 26, 2025 | -2.78 Bn |
| Jun 27, 2025 | -247.00 Mn |
| Jun 27, 2025 | -247.00 Mn |
| Mar 28, 2025 | -1.26 Bn |
| Mar 28, 2025 | -1.26 Bn |
| Dec 31, 2024 | -1.69 Bn |
| Dec 31, 2024 | -1.69 Bn |
| Sep 27, 2024 | -845.00 Mn |
| Sep 27, 2024 | -845.00 Mn |
| Jun 28, 2024 | -5.72 Bn |
| Jun 28, 2024 | -5.72 Bn |
| Mar 29, 2024 | -133.00 Mn |
| Mar 29, 2024 | -133.00 Mn |